Forward P/S Multiple: SmartVest (ELMD)

Electromed - graphic logo of issuer ELMD

Electromed, Inc. (ELMD) is developing the SmartVest digital environment for lung therapy, while direct system sales are enhancing margins. The forward P/S dynamics for the company clearly demonstrate market revenue expectations, where the indicator value is 2.30. Investors can derive a real-time valuation of the business based on its leadership in airway clearance and the absolute trust of COPD patients.

Electromed - ELMD Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for smartvest.com (ELMD)

- market price and analyst price targets:
Price Chart Electromed|ELMD - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization ELMD|ELMD - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Electromed, Inc.|ELMD - Accounting Capitalization|Market Capitalization to Book Value Ratio smartvest.com|ELMD - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Electromed, Inc.|ELMD - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Electromed|ELMD - Company Aggregate Debts|Debt to Book Capitalization Ratio ELMD|ELMD - Company Long-Term Debt|Company Current Liabilities Electromed, Inc.|Quick Ratio smartvest.com
- financial results and valuation multiples details:
ELMD - Company Net Income|Expected Profit Electromed, Inc.|ELMD - Market Cap to Net Income Ratio|Projected Price to Earnings Electromed|ELMD - PEG Multiple|EV/EBITDA Multiple ELMD|ELMD - Operating income before deduction of amortization|Earnings per share for the last twelve months Electromed, Inc.|ELMD - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months smartvest.com|ELMD - Net earnings per share growth this year|Earnings growth forecast for next year Electromed, Inc.
- sales and revenue indicators:
ELMD - Company Total Revenue|Company Projected Revenue Electromed|ELMD - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple ELMD
Fundamental company analysis:ELMD (Electromed Inc)
Product sample of smartvest.com

For Electromed, Inc. (ELMD), this indicator serves as a gauge of market expectations regarding sales growth rates for therapeutic equipment amid a dependence on Medicare insurance payments. By analyzing the company's projected P/S ratio, an investor compares current market capitalization with forecasted revenue, allowing for an assessment of the asset's overbought status and the risks of a correction should planned sales targets in this narrow niche not be achieved.

Who Electromed, Inc. competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|LNSR (LENSAR, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio avitamedical.com RCEL|Price-to-Projected Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Projected Price to Revenue|EDAP TMS - Forward Price-to-Revenue Multiple|Forward P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Market Cap to Future Revenue Ratio profusa.com (PFSA)|Price-to-Projected Revenue Ratio STRATA Skin Sciences Inc.|Price-to-Projected Revenue Ratio GCTK|Forward P/S Multiple NAOV|VERO - Market Cap to Future Revenue Ratio|Forward P/S Multiple NUWE (Nuwellis, Inc.)|AEMD - Forward Price-to-Revenue Multiple|ASXC: Forward Price-to-Revenue Multiple|Avinger Inc. - Price to Expected Revenue Ratio|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|Cutera Inc - Forward Price to Sales|Price-to-Projected Revenue Ratio Know Labs, Inc.|Market Cap to Future Revenue Ratio inarimedical.com NARI|Price-to-Projected Revenue Ratio Nevro (NVRO)|Forward Price-to-Revenue Multiple reshapelifesciences.com RSLS|Forward P/S Multiple SILK (Silk Road Medical Inc.)